Partnerships
The best partner to accelerate your drug success
Humanized mice have demonstrated their contribution of high-success probability in past 30 years. But through lens of our advantageous gene-editing technology, we still see much unveiled benefits outside of industry’s reach. The unique technology allows us to remove the last barrier between your target and its human antibody more easily.
Reach Out To Us
bd@immunocan.com
Your business requirement is just as unique as your drug program. We offer fitting partnership models to accelerate our collaboration.
Antibody focused joint research, join us to see the B cell repertoire advantage of Gene-edited animal with favored royalty free offer.
Technology focused platform license, use the animals as part of your Research and Development team.
Challenging project focused customizing solution, leverage our gene-editing technology to engineer the animal to overcome your program hurdles.
Beyond animal-based collaboration, we offer integrated discovery service suite supporting antigen preparation through lead identification, streamlining the whole molecule discovery journey with either in-house capabilities or CRO partners.
Featured in-house capabilities
- Project-customizable to meet Target product profile oriented repertoire-characteristic generation, for high affinity, high specificity or other characteristic of interest.
- Optimized for compatible with different antigen strategies: protein-based and genetic immunization.
Expanded capabilities - CRO partners
